Brenntag Purchases UK Packed Glucose Syrup Business from Cargill
Advertisement
Brenntag UK Ltd, part of the Brenntag Group, announced the purchase of the Goodwill relating to the Packed glucose Syrup business in the UK from Cargill plc. The agreement includes the supply of all grades of Glucose syrup in packages to UK customers.
For many years Brenntag has operated a toll packaging and distribution arrangement for Cargill from the Trafford Park facility, whilst also acting as an official distributor of the C* range of Glucose Syrups.
For Brenntag, the acquisition of this business represents an important further step into a growing market sector. In addition, Brenntag has signed a long-term supply agreement with Cargill to ensure continuity of supply.
Brenntag will officially take responsibility for the customer base on 1st September 2009.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Siegfried Group reports drop in revenue
SIMONA to acquire Boltaron - Second acquisition in North American market
Lifesavers in Demand: New Market Report on Flame Retardants
Elemica to Launch Global Multi-Modal Logistics Platform for the Chemical Industry - Acquires Optimum Logistics
New NanoMarkets Report Identifies Trends and Opportunities in Thin-Film Silicon Photovoltaic Materials
UCB Receives FDA Orphan Drug Designation for Brivaracetam for the Treatment of Symptomatic Myoclonus
Accenture to Acquire LabAnswer - Expanding life sciences and cross-industry research and laboratory informatics capabilities
Aventis implements SciQuest's Enterprise Substance Manager to establish common logistics infrastructure for research facilities
